The Role of AHI1 and CDKN1C in Cutaneous T-cell Lymphoma Progression

Overview

Journal Exp Dermatol

Specialty Dermatology

Date 2012 Nov 23

PMID 23171462

Citations 17

Authors

Ivan V Litvinov

Thomas S Kupper

Denis Sasseville

Affiliations

Soon will be listed here.

Abstract

Cutaneous T-cell lymphoma (CTCL) is the most common lymphoma of the skin. Recent reports suggest that AHI1 is overexpressed in a subset of CTCL-derived cell lines, where it downregulates the expression of CDKN1C tumor suppressor gene. In the current work, we test the expression of these genes in 60 patients with Mycosis Fungoides and Sezary Syndrome by RT-PCR and correlate our findings with 6 years of clinical follow-up. These findings reveal that AHI1 and CDKN1C exhibit opposite expression patterns, where AHI1 is expressed in poor and intermediate prognosis patients, while CDKN1C is expressed in favourable prognosis patients. Kaplan-Meier analysis documents that downregulation of CDKN1C is associated with poor disease outcome in patients with CTCL, while upregulation of AHI1 shows a weak association with aggressive disease course.

Citing Articles

Ectopically Expressed Meiosis-Specific Cancer Testis Antigen HORMAD1 Promotes Genomic Instability in Squamous Cell Carcinomas.

Gantchev J, Messina-Pacheco J, Martinez Villarreal A, Ramchatesingh B, Lefrancois P, Xie P Cells. 2023; 12(12).

PMID: 37371097 PMC: 10296909. DOI: 10.3390/cells12121627.

The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review.

Ramchatesingh B, Martinez Villarreal A, Arcuri D, Lagace F, Setah S, Touma F Int J Mol Sci. 2022; 23(20).

PMID: 36293471 PMC: 9603842. DOI: 10.3390/ijms232012622.

Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients.

Martinez Villarreal A, Gantchev J, Lagace F, Barolet A, Sasseville D, Odum N Cancers (Basel). 2020; 12(8).

PMID: 32707930 PMC: 7465783. DOI: 10.3390/cancers12082007.

Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C.

Yang C, Yan Z, Hu F, Wei W, Sun Z, Xu W Cancer Cell Int. 2020; 20:32.

PMID: 32015692 PMC: 6990552. DOI: 10.1186/s12935-019-1064-y.

Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome leukemic cell lines.

Netchiporouk E, Gantchev J, Tsang M, Thibault P, Watters A, Hughes J Oncotarget. 2017; 8(56):95981-95998.

PMID: 29221181 PMC: 5707075. DOI: 10.18632/oncotarget.21619.

References

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

van Kester M, Borg M, Zoutman W, Out-Luiting J, Jansen P, Dreef E . A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. J Invest Dermatol. 2012; 132(8):2050-9. DOI: 10.1038/jid.2012.117. View

Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50(3):163-70. View

Litvinov I, Jones D, Sasseville D, Kupper T . Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Clin Cancer Res. 2010; 16(7):2106-14. PMC: 2853253. DOI: 10.1158/1078-0432.CCR-09-2879. View

Slater D . The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005; 153(5):874-80. DOI: 10.1111/j.1365-2133.2005.06905.x. View

Lamberg S, Bunn Jr P . Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute Workshop. Arch Dermatol. 1979; 115(9):1103-5. DOI: 10.1001/archderm.115.9.1103. View

Shin J, Monti S, Aires D, Duvic M, Golub T, Jones D . Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood. 2007; 110(8):3015-27. PMC: 2018675. DOI: 10.1182/blood-2006-12-061507. View

Kennah E, Ringrose A, Zhou L, Esmailzadeh S, Qian H, Su M . Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Blood. 2009; 113(19):4646-55. DOI: 10.1182/blood-2008-08-174037. View

10.

Knol A, Quereux G, Brocard A, Ballanger F, Khammari A, Nguyen J . About the cutaneous targets of bexarotene in CTCL patients. Exp Dermatol. 2009; 19(8):e299-301. DOI: 10.1111/j.1600-0625.2009.00995.x. View

11.

Vega F, Luthra R, Medeiros L, Dunmire V, Lee S, Duvic M . Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 2002; 100(9):3369-73. DOI: 10.1182/blood.V100.9.3369. View

12.

Ringrose A, Zhou Y, Pang E, Zhou L, Lin A, Sheng G . Evidence for an oncogenic role of AHI-1 in Sezary syndrome, a leukemic variant of human cutaneous T-cell lymphomas. Leukemia. 2006; 20(9):1593-601. DOI: 10.1038/sj.leu.2404321. View